Reporter Oct 16 2020 Archive
-
October 15, 2020
Study explores nicotine patch to treat late-life depression
Backed by nearly $5 million in funding, researchers from Vanderbilt University Medical Center are testing to see whether transdermal nicotine patches can improve mood, forgetfulness and attentiveness in adults over 60 with a diagnosis of depression. -
October 15, 2020
Factor involved in stomach injury response identified
Researchers at Vanderbilt University Medical Center have identified a key factor that coordinates the body’s repair response to severe injury in the stomach caused, most commonly, by infection by the bacterium Helicobacter pylori. -
October 15, 2020
Brain blood vessel response to hypoxia
The brain’s response to low oxygen — growth and remodeling of blood vessels — involves certain cell types and molecular pathways, Vanderbilt researchers have discovered. -
October 15, 2020
Initiative seeks to extract cancer phenotypes from electronic health records
The National Cancer Institute (NCI) has funded the development of interactive visual tools that will allow researchers to extract cancer phenotypes from electronic medical records. -
October 14, 2020
Bacchetta named associate chair of Thoracic Surgery
Matthew Bacchetta, MD, MBA, MA, associate professor of Thoracic Surgery, has been named associate chair of Vanderbilt University Medical Center’s Department of Thoracic Surgery, effective Sept. 1. -
October 13, 2020
COVID-19 long-acting antibodies discovered by Vanderbilt University Medical Center move to phase 3 clinical trials
AstraZeneca is advancing into phase 3 clinical trials with an investigational COVID-19 therapy of two long-acting antibodies discovered by Vanderbilt University Medical Center and optimized by AstraZeneca.